SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-23-038560
Filing Date
2023-10-27
Accepted
2023-10-27 17:23:48
Documents
3
Period of Report
2023-10-27

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 221400
2 proxy_001.jpg GRAPHIC 840792
3 proxy_002.jpg GRAPHIC 739283
  Complete submission text file 0001493152-23-038560.txt   2398663
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40023 | Film No.: 231356448
SIC: 2834 Pharmaceutical Preparations